Thursday, 23 February 2017

Global Automated Dispensing Systems Market by Type & Application 2016 - 2024

Automated dispensing systems deliver a balance between security, user-friendliness, inventory management, and control of medications, which are all acknowledged as imperative features of a safe medication distribution system. These features drive the global automated dispensing systems market. Other drivers of the market include increasing demand for rapidly generated electronic reports to help categorize and prevent potential diversion from patient’s current health status. Automated dispensing systems save nursing time by reducing the need for manual end-of-shift counts in patient care division. Moreover, there is growing demand for automated systems such as barcodes and RFID cabinets, which help stock management and inventory management. These are the key factors expected to drive the market in the next few years. Moreover, increase in global geriatric population and prevalence of various chronic diseases, as well as high rates of hospitalization are some of the factors increasing the burden on hospital pharmacies and retail drug stores, consequently increasing demand for automated dispensing systems. Increase in the number of prescriptions and lack of skilled pharmacists are the other factors expected to boost automation in medication dispensing.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.


Improving patient’s health and safety is always a primary objective in hospital and health care settings, and pharmacologists have been discovering a variety of policies and technologies to achieve this objective. Automated dispensing system, also termed as automated drug cabinet, is an electronic drug storage and dispensing device primarily used in health care settings. These systems provide easy to operate computer-controlled storage, dispensing, and tracking of medicine. These systems have been recommended as one of the potential instruments to improve efficiency and patient safety, and they are now widely used in many hospitals, for instance in clinics, nursing homes, are located at the point of care settings (POC), for example in an accident & emergency department (A&E), diagnostic labs, an intensive care unit (ICU), and critical care unit (CCU).

The global automated dispensing systems market has been segmented based on product type, end-user, and region. In terms of product type, the market has been segmented into centralized automated dispensing systems and de-centralized automated dispensing systems. Centralized automated dispensing systems are sub-segmented into robotic automated systems and manually operated unit-dose system. Decentralized systems which provide computer controlled storage, tracking of medications, and dispensing have been recommended widely and are expected to hold large market share in the near future.

Based on end-user, the global automated dispensing systems market has been segmented into pharmacy stores, hospitals, laboratories, and others. The hospitals segment is anticipated to account for major share of the automated dispensing systems market driven by rapidly increasing health care expenditure and rising patient admissions which increases burden on pharmacy departments. The hospitals segment has been sub-segmented into general ward and emergency ward. The pharmacy stores segment is expected to expand at a high CAGR during the forecast period. Increasing pressure on pharmacies due to rising drug prices and decline in reimbursements leads to inefficient inventory and supply chain management. However, human error can lead to medication dispensing errors. This in turn is expected to boost the growth of the pharmacy stores segment during the forecast period.

North America accounted for major share of the global automated dispensing systems market. This is attributed to increased concerns toward patient’s health and safety. Europe was the next major market for automated dispensing systems. However, Asia Pacific is expected to witness significant growth during the forecast period. Key growth drivers of the automated dispensing systems market in the region include increasing geriatric population and rising health care expenditures.

Major players operating in the automated dispensing systems market are Aesynt Incorporated, Becton, Dickinson and Company, Omnicell, Inc., Pearson Medical Technologies, RxMedic Systems, Inc., Avery Weigh-Tronix, ScriptPro LLC, Capsa Solutions, LLC, and Cerner Corporation, among others.

Browse Full Research Report on Automated Dispensing Systems Market:
http://www.transparencymarketresearch.com/automated-dispensing-systems-market.html

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Smart Cards in Health Care Market Key Trends & Industry Forecast 2016 - 2024

The global smart cards in health care market is anticipated to be driven by a number of factors such as growing demand for better patient data management systems and increasing inclination for electronic data management approaches. In addition, growing stress on patient data safety is expected to drive the market. Furthermore, increasing research and development activities by key players to develop new products is projected to boost market growth. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

A smart card is a small plastic card with an embedded integrated circuit (IC) chip. This integrated circuit (IC) chip is a microprocessor that makes the smart card suitable for different electronic applications. The chip on the card is used to store, manage, calculate, and safely access some personal valuable data or information when needed by a card reading machine or other system. Smart cards use encrypted algorithms for data management and are considered safer than magnetic strip cards. Smart cards are widely used to handle sensitive information such as identity, finances, and personal health information due to their added security features. Smart cards are also used in several key applications such as health care services, banking and financial corporations, entertainment, telecommunications, government authorities, and transportation.


Smart cards in the health care sector have gained massive popularity in the last decade. This can be attributed to several value added features that smart card usage can offer to patients as well as providers. With the health care boom in the last few decades, maintenance of health data has become a necessity, yet tiring process in large facilities. Health care organizations globally are extensively using smart health cards that offer an extensive range of applications. Smart cards in health care can help enhance the security and confidentiality of patient data, maintain accurate patient identification across different facilities and geographies, provide secure access to emergency medical information, easy bill payment using the card for a financial transaction, reduce health care fraud, offer a secure medium for convenient medical records, and permit better compliance with government initiatives and instructions.

Based on products, the smart cards in health care market can be divide into contact-based smart cards, contactless smart cards, dual-interface smart cards, and hybrid smart cards. Contact-based smart cards comprise a gold chip that needs a smart card reader to access and interpret data, while contactless smart cards contain a microprocessor chip and an antenna coil that enables them to work faster than contact cards. Another key driver of the market is tamper-proof data storage. Advancements in product technology and rising awareness among the common people about the benefits of smart cards is also expected to increase demand in the near future.

In terms of region, the smart cards in health care market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America and Europe have been dominating the market due to high acceptance of digital mediums in the regions. According to a research study conducted by the Workgroup for Electronic Data Interchange (WEDI), smart cards usage in health care could decrease the error rate of mismatched patient data from 10% to 15% to as low as 2%. Additionally, new and advanced technology such as hybrid cards launched by various market players coupled with growing online campaign and acceptance of these products by customers is expected to drive the market. Developing nations in Asia Pacific are expected to witness the fastest growth during the forecast period. Growing patient pool, increased public awareness, and increasing affordability are the major drivers of the market in these geographies. 

Some of the players in the smart cards in health care market are Atos SE, American Express Company, CardLogix Corporation, Giesecke & Devrient (G&D) GmbH, Gemalto NV, Infineon Technologies AG, INSIDE Secure SA, Oberthur Technologies SA, SCM Microsystems, and VeriFone Holdings, Inc.

Browse Full Research Report on Smart Cards in Health Care Market:
http://www.transparencymarketresearch.com/smart-cards-in-health-care-market.html

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Ophthalmic Ultrasound Device Market Share by Industry Research 2016 - 2024

The constantly increasing percentage of the geriatric population across the world is widely considered as the primary factor augmenting the demand for ophthalmic ultrasound devices. The high geriatric population is directly linked to the increasing patient count for ocular diseases and disorders, along with chronic diseases such as diabetes. The increasing levels of pollution are also responsible for the high volume of ovular disorders across the world, thereby becoming a key driver for the global ophthalmic ultrasound device market. This market is further being boosted by the need for – and subsequent release of – novel technological developments. However, the global ophthalmic ultrasound device market is also being stifled by factors such as the high costs of acquiring these devices as well as the overall lack of ophthalmologists capable of operating advanced devices.

According to the NHS, in the U.K., between 500 and 600 cases of ocular cancer are diagnosed per year, a key concern among the region’s ophthalmologists. This is likely to drive the growth of the European ophthalmic ultrasound devices market. At the same time, Asia Pacific is projected to lead the global ophthalmic ultrasound device market in terms of growth rate over the above forecast period. This prediction is based on the region’s increase in geriatric population, the setup of stronger distribution channels by market leaders, and an improving patient awareness program regarding ocular disease management.

The global ophthalmic ultrasound device market was valued at US$2.3 bn in 2015. Its revenue is expected to expand at a CAGR of 6.2% within a forecast period from 2016 to 2024 and is estimated to reach US$4.0 bn by the end of 2024.

Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=6583

A-scan Ophthalmic Ultrasound Devices High in Demand

Based on products, the global ophthalmic ultrasound device market can be segmented into A-scan, B-scan, combined scan, pachymeters, and ultra-bio microscopes (UBM). In terms of value, A-Scan segment emerged as the leading product segment in the global ophthalmic ultrasound device for 2015, accounting for 27.8% of its overall value. A-scan devices are largely used in hospitals, ophthalmic clinics, and research labs to gather results with higher accuracy. The segments of combined scan and B-scan are expected to register an exceptionally fast growth in demand over the given forecast period. Their growth rate is attributed to an increase in the number of cataracts, glaucoma, and other common ocular diseases. UBM devices are projected at an improved growth rate between 2016 and 2024, owing to an increasing rate of technological advances in this segment.

Ophthalmic ultrasound devices are used by end users ranging from ophthalmic clinics, eye research institutes, hospitals, and ambulatory surgical centers. Hospitals dominated the market in 2015 owing to an increasing registration rate of various ocular diseases and the growing scope of device customization offered by several key players. This segment is also expected to grow at a leading rate till 2024.

High Patient Count in North America Puts it at Top of Ophthalmic Ultrasound Device Demand

Geographically, the global ophthalmic ultrasound device market is divided into North America, Europe, Asia Pacific, Latin America, and The Middle East and Africa. North America emerged as the leader in the global ophthalmic ultrasound device market for 2015 with a strong share of 39.8% in its value. This factor is attributed to the rising prevalence of ocular disorders and a significantly higher rate of development of technologies, and better ocular health awareness programs than other regions.
For 2015, the leaders in the global ophthalmic ultrasound device market included Nidek Co. Ltd., Ellex Medical Lasers Ltd., Optos Plc. (Nikon Corporation), Halma Plc., Sonomed, Inc. (Escalon Medical Corp.), Reichert, Inc. (AMETEK, Inc.), and Quantel Medical.

Browse Full Research Report on Ophthalmic Ultrasound Device Market:
http://www.transparencymarketresearch.com/ophthalmic-ultrasound-systems-market.html

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Phototherapy Equipment Market Analysis by Global Segments, Size and Forecast 2016 - 2024

The global phototherapy equipment market has been segmented based on product type, end-user, application, and region. Products based on body type are full body type and partial body type. Products based on lamp type include fluorescent tubes (white, blue, green), halogen lamps, fiberoptic systems, and LEDs. In terms of end-user, the global phototherapy equipment market has been segmented into hospitals, diagnostic labs, and others. Based on application, the market has been segmented into neonatal care and dermatology. Dermatology includes psoriasis, vitiligo, eczema, and others (acne, etc.).

Phototherapy is the treatment of disease or disorder by exposure to ultraviolet or infrared radiation. The main types of phototherapy broadband are UVA (PUVA and UVA1) and UVB. The most used phototherapy broadband is narrow band UVB light, which is less than 1% of the total wavelength from sunlight and has maximum absorption at wavelength at 311 nm. The patient is exposed to the selected monochromatic spectrum for a defined interval of time repeatedly under a physician’s observation in a controlled environment. Currently, narrow band UVB is the most used broadband due to advantages such as phototherapy treatment using narrow band UVB light provides quicker clearing, reduced amount of sun burn, and faster disease recovery than traditional UVB. Especially in psoriasis and vitiligo cases, narrow band UVB is considered gold standard as it helps in repigmentation of skin and is tolerated well in children as well as adults. Physician guided narrow band UVB phototherapy treatment is a well-tested, fast, and effective option with nearly no side effects. Recent advances in phototherapy equipment and increasing awareness in developing countries about the treatment of dermatological diseases present large opportunities for companies in the global phototherapy equipment market.


Major market players in the global phototherapy equipment market have various advantages such as cutting edge technologies, superior research and development, technologically advanced instruments, and skilled workforce for phototherapy equipment manufacturing. The global phototherapy equipment market is driven by increasing demand from health care professionals across the world for advanced phototherapy products, increasing focus by companies to provide quality products, increasing incidence and prevalence of dermatological disorders and chronic diseases. However, stringent regulatory guidelines regarding the use of phototherapy products and competitive cost of products are some factors restraining the global phototherapy equipment market.

Unique product specifications and superior technological advancements present significant opportunities in the global phototherapy equipment market. Availability of better diagnostic facilities, increasing improvements in R&D sector, and rising occurrence of neonatal jaundice, psoriasis, eczema, etc. are some of the factors attributed to the high growth of the global phototherapy equipment market. Widespread acceptance of phototherapy, key technical inventions, and strategic collaborations of companies in the developing countries are expected to boost the growth of the phototherapy equipment market. The risk associated with phototherapy treatment include skin irritation or skin burning due to frequent UV broadband exposure.

In terms of region, the global phototherapy equipment market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in Asia Pacific is projected to witness the highest growth driven by high prevalence of dermatological infection and neonatal jaundice, increasing adoption of new techniques in phototherapy products, and low cost of phototherapy products and treatment. North America dominates the global phototherapy equipment market, owing to factors such as increasing demand for better health care facilities and invention of effective phototherapy equipment combinations as a result of extensive research and development.

Key players in the global phototherapy equipment market are Herbert Waldmann GmbH & Co. KG, General Electric Company (GE Healthcare), Solarc Systems, Inc., National Biological Corp., Honle UV America, Inc., Nice Neotech Medical Systems Pvt. Ltd., Koninklijke Philips N.V., UVBioTek, LLC, and ibis Medical Equipment & Systems Pvt. Ltd. 

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Full Research Report on Phototherapy Equipment Market:
http://www.transparencymarketresearch.com/phototherapy-equipment-market.html

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Global Antinuclear Antibody Test Market Share by Industry Research 2016 - 2024

The antinuclear antibody test reagents market has been segmented by test type, product type, end-user, and geography. In terms of test type, the antinuclear antibody test market is classified into ELISA, IFA, and Dot Blot test. In terms of product type, the market is classified into assay kits and reagents. In terms of end-user, the antinuclear antibody test market is classified into hospitals, clinics, diagnostic centers, and research laboratories. The hospitals segment is expected to contribute a significantly large share due to developed infrastructure and safety test procedure. Geographically, the market is classified into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

Factors such as growth in health care awareness among people and increase in prevalence of autoimmune diseases, such as rheumatoid arthritis and type I diabetes, are driving the global antinuclear antibody test market. According to WHO, the number of people suffering from diabetes has increased from 108 million in 1980 to 422 million in 2014, and it is expected to increase further in the near future. Other factors such as government health care insurance & reimbursement policies and increase in health care expenditure are projected to fuel the antinuclear antibody test market. However, factors such as stringent regulation for product approval, diagnostic errors, and unavailability of skilled labor are estimated to hinder the antinuclear antibody test market globally.

Download Exclusive Global Strategic Business Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17930

Antinuclear antibody test is a sensitive screening test used to diagnose autoimmune disorders. The test is used in symptoms such as low-grade fever, skin sensitivity to light, persistent fatigue, weakness and inflammation, and damage to organs and tissues. The test gives two types of results: positive result and negative result. A positive test indicates the presence of autoantibody. Enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA) are the two types of tests commonly performed to detect antinuclear antibody test. ELISA test results are reported as arbitrary units, and IFA test results are reported as rations, for example 1:320, which indicates one part of blood sample was mixed with 320 parts of a diluting substance. About 95% of antinuclear test is used to test lupus autoimmune disease. Lupus disease is followed by scleroderma (systemic sclerosis) and Sj√∂gren’s syndrome which shows positive results in about 60% and 40% cases, respectively. The prevalence of antinuclear antibody in healthy individuals is about 3% to 15% and production of autoantibody is age dependent, which increases from 10% to 37% over age 65. The antinuclear antibody test further provides additional diagnostic and prognostic information about the nature of the autoimmune process based on the targeted antigens. Other therapeutic conditions with modest frequency of antinuclear antibody are thyroid, rheumatoid arthritis, HIV, and hepatitis C.

Geographically, North America dominates the market owing to early disease diagnosis, growth in number of autoimmune diseases such as lupus, developed health care infrastructure, and large number of geriatric population. These factors are estimated to drive the antinuclear antibody test market in the region. According to Lupus Foundation of America, 1.5 million Americans and approximately 5 million people are living with lupus disease. North America is followed by Europe with a large market for antinuclear antibody test. Asia Pacific is expected to grow at a higher rate during the forecast period due to rapid rise in population, high prevalence of autoimmune disorders, increase in public awareness, and improvement in health care infrastructure, which in turn boost the antinuclear antibody test market. Growing number of government awareness campaigns is the driving factor boosting patients to seek clinical diagnostics even for disease symptoms. Other emerging countries such as Brazil and South Africa are anticipated to create a large opportunity for the antinuclear antibody test market.

Major players operating in this market include Alere Inc., Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Bio-Rad Laboratories, Inc., Becton Dickinson and Company, Biocom Biotech, Erba Diagnostics, ZEUS Scientific, Inc., and F. Hoffmann-La Roche Ltd.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Browse Full Research Report on Antinuclear Antibody Test Market:
http://www.transparencymarketresearch.com/antinuclear-antibody-test-market.html

About Us    

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.